Award details

Creating a bovine C-type lectin receptor atlas and identification of their ligands

Reference	BB/P008461/1
Principal Investigator / Supervisor	Professor Dirk Werling
Co-Investigators / Co-Supervisors	Dr Denis Larkin
Institution	Royal Veterinary College
Department	Pathology and Pathogen Biology
Funding type	Research
Value (£)	455,362
Status	Completed
Type	Research Grant
Start date	01/04/2017
End date	13/03/2021
Duration	47 months

Abstract

In the work proposed here, we will identify genes encoding C-type lectin receptors (CLRs) within the bovine genome and characterise the ligand-binding spectrum of selected CLRs. This knowledge will be subsequently used to investigate the functions of the selected CLRs in normal immune system homoeostasis as well as to assess their roles in binding and uptake of specific (and sometimes zoonotic) pathogens. We will build on preliminary studies performed in the laboratories of the two Principal Investigators to validate differences in ligand-binding of bovine CLRs compared to their human/murine counterparts, and to assess the immune response of antigen-presenting cell subsets to antigens delivered by CLR ligands. The test systems developed within this proposal will use state-of-the art lectin arrays to identify the ligand-binding spectrum of bovine CLRs. Given the existing knowledge of human CRL binding to specific pathogens, we will subsequently assess the importance of identified CLRs in the binding/uptake of Mycobacterium bovis, Listeria monocytogenes and bovine viral diarrhoea virus. All of these diseases are endemic in UK livestock and pose major animal/public health concerns with significant impacts on food security, food safety and economic productivity. We will investigate which pathogens are recognised and which glycans mediate the recognition by bovine CLRs, to identify new intervention strategies. Major outputs will include an on-line atlas of CLRs encoded in the bovine genome including, where possible, annotation of their specific chromosomal locations; documentation of the ligand-binding spectrum of these CLRs using glycan arrays; and demonstration of the functions of the CLRs in normal antigen-presenting cell - T cell interactions. A further key outcome will be an assessment of the importance of specific CLRs in the binding and uptake of (zoonotic) pathogens, with the ultimate aim of bridging the gap between tool development and practical use.

Summary

The innate immune system is the first line of defence against invading pathogens. Cells of the innate immune system, such as macrophages and dendritic cells express a variety of receptors that bind to sugar (glycan) targets. These receptors, known as lectins, perform a dual function: under non-infectious conditions, they support the normal function of the immune system through enhancing the interaction of macrophages/dendritic cells with T cells. Under infectious conditions, they aide the recognition of pathogens that express specific glycan motifs in case of an infection. Distinguishing host cells from pathogens by these receptors derives from their ability to bind pathogen-specific surface sugars. Recently, the idea of using glycan structures as vaccine adjuvants/vaccine delivery systems to target specific innate immune cell subsets through the sugar-binding receptors has been explored. Using this approach robust humoral and cellular immune responses have been induced in mice. Thus, in addition to providing an understanding of innate immune cell - T cell interaction in farm animals in more detail, the proposed work will provide a basis for exploiting adjuvant-like properties of glycans themselves resulting from their ability to activate both inflammatory and phagocytic receptors expressed on antigen-presenting cells. Our preliminary data demonstrate that there are substantial differences between the glycan-receptors expressed in different mammalian species, and the ligands that they recognise. This observation has important implications for vaccine design for farm animals, specifically ruminants as studied here, as it means that vaccine adjuvants designed and tested in the human and/or murine system may not work in other mammalian species, a fact supported by the recent failure of mycobacterial vaccines in the appropriate host. Thus, identifying the glycan (lectin) receptors in the bovine genome and understanding their function may provide new avenues to understand the first steps in host pathogen interaction. As the key way of reducing antibiotic dependence, and thus the reduction of AMR is to improve current vaccine strategies, the gained knowledge may also provide the basis for the development of more host-specific adjuvant/vaccine-delivery systems.

Impact Summary

This research contributes to the BBSRC strategic plan Strategic Research Priority 1 - Agriculture and Food Security, specifically under the aspects of Animal Health and Welfare and Development of Next Generation Vaccines. It will underpin long term commercial aims for improved therapeutic and preventative methods to reduce infectious disease in cattle by identifying new ways to deal with increased AMR. Through comparing the function of CLR in rodents, human and ruminants, this project will also fall under the priority of functional and comparative genomics. Outcomes will assist in increasing UK competitiveness in the global animal production market, improving animal welfare and helping to guarantee a secure supply of safe, healthy food. The following stakeholders will benefit from this work. 1. The cattle industry Cattle production and welfare benefit from many vaccines with various efficacies. Identification of new vaccine targets/vaccine adjuvants based on sugar-motifs recognised by appropriate receptors can potentially revolutionise how infectious diseases are treated, thus increasing production, improving economic performance, welfare and life-span of animals. Our close relationships with industry representatives can fast track the results into field use. Findings will be relevant to vaccines targeting other pathogens in cattle, as well as pigs and chicken. 2. The animal health industry Whereas carbohydrate-based vaccines are already used in human medicine (S. pneunomiae, N. meningitides, H. influenza), their development is still in its infancy in veterinary medicine, due to lack of understanding of presence and functionality of these receptors in farm animals. Being able to develop such carbohydrate-based vaccine would potentially provide means of replacing anti-microbial therapies for bacterial infections, for which there are constantly increasing risks of resistance development, such as Mycobacteria spp., E. coli, Salmonella spp, and Staphylococci. These diseases do not only provide potential zoonotic problems, but are also considered to be the main agents for some of the most economically important diseases for the cattle industry in the UK, causing mastitis and bTB. 3. Animal welfare The expectation today is that all farm livestock should have "a life worth living - from their point of view" (Farm Animal Welfare Council, 2009). Welfare would benefit if health status is improved. This proposal may provide the basis for development of carbohydrate-based vaccines in ruminants and, if successful, encourage farmers to potentially change their approach in treating specific infectious diseases, reducing their reliance on antimicrobial drug therapy. 4. General public and the environment Increased efficiency in cattle production will raise cattle product availability at a lower cost for the consumer, contributing to improved food security. Consequences of improved pathogen control include a reduction in the requirement for chemoprophylaxis/anti-microbial treatment, reducing drug consumption, the risk of contamination to the food chain and the environment, and selection for drug resistance. All investigators are actively engaged in public dissemination of UK research. Students at all levels of education can benefit from the principles established in this work. 5. Skills, knowledge and training The multidisciplinary nature of this project will provide opportunities for broad training to all staff, in addition to other members and students of each host institution, strengthening the research community in the areas of disease control and vaccine development. Broader impact can be achieved using avenues such as the UK Veterinary Vaccines Network. 6. International development Infectious diseases impose serious costs on animal production in developing counties. Translating high quality, innovative, strategic research within UK universities into cheap, efficacious vaccines can improve economic income and alleviate poverty.

Committee	Research Committee D (Molecules, cells and industrial biotechnology)
Research Topics	Animal Health, Immunology, Microbiology
Research Priority	X – Research Priority information not available
Research Initiative	X - not in an Initiative
Funding Scheme	X – not Funded via a specific Funding Scheme

Associated awards:

BB/P005659/1 Creating a bovine C-type lectin receptor atlas and identification of their ligands

I accept the terms and conditions of use (opens in new window)

export PDF file

back to list new search